department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Autolus Therapeutics plc ($AUTL) · pharmadog

PUBLIC COMPANY

$AUTLAutolus Therapeutics plc

London, GBupdated 1mo ago

SEC EDGAR ↗Yahoo Finance ↗

community read0 votes

pipeline

2

marketed

0

phase 3

1

catalysts ytd

0

approvals ytd

0

recalls ytd

0

Pipeline(2)

pipeline depth2 products

1Phase 21Phase 3

obecabtagene autoleucel

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…

B-lymphocyte antigen CD19

B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphobla…

Upcoming

no upcoming catalysts on record

Recent(90d)

nothing in the last 90 days

view all catalysts →

🐶 Hiring Signal

No open roles indexed yet — view Autolus Therapeutics plc jobs →

News

no news has mentioned this company yet

identifiers

ticker

$AUTL

SEC CIK

0001730463

country

GB

source

sec_tickers

top tags

Oncology2 Immunology1

mentioned in

0news items

entity-linker matched

$AUTL

Data sources

last refreshed 37m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

Active trials

phase2A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)active not recruitingn=153
phase1Obe-cel in Refractory Progressive Forms of Multiple Sclerosisrecruitingn=18
phase2Phase I/II Study Evaluating AUTO4 in Patients With T Cell Receptor Beta Constant (TRBC)1 Positive T Cell Lymphomaterminatedn=20
phase1A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)recruitingn=30
phase1Obe-cel in Adolescent [Applicable in UK Only] and Adult Severe, Refractory Systemic Lupus Erythematosusrecruitingn=18
—Expanded Access Program for OOS Obe-celavailable
phase2Obe-cel in Severe, Refractory Systemic Lupus Erythematosus With Active Lupus Nephritisnot yet recruitingn=35
phase2Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cellsenrolling by invitationn=500

more trials →

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?